NIH APPROVED Ivermectin as Treatment for covid19

Listed 2nd in table after Remdesivir

https://www.covid19treatmentguidelines.nih.gov/tables/table-2e/

https://archive.is/92Jhz

From table

Adults:

The dose most commonly used in clinical trials is IVM 0.2–0.6 mg/kg PO given as a single dose or as a once-daily dose for up to 5 days

Generally well tolerated

Dizziness

Pruritis

GI effects (e.g., nausea, diarrhea)

Neurological AEs have been reported when IVM has been used to treat parasitic diseases, but it is not clear whether these AEs were caused by IVM or the underlying conditions.

Monitor for potential AEs.

Minor CYP3A4 substrate

P-gp substrate

Generally given on an empty stomach with water; however, administering IVM with food increases its bioavailability.2

A list of clinical trials is available here: Ivermectin

https://clinicaltrials.gov/ct2/results?cond=COVID-19&term=ivermectin&cntry=&state=&city=&dist=&Search=Search

78 trials noted and RECRUITING for more trials OUTSIDE U.S.

h/t https://greatawakening.win/p/13zMs72Ccr/ivermectin-is-approved-by-the-ni/c/